Terms: = Endocrine gland cancer AND SRC, c-SRC, 6714, ENSG00000197122, P12931, ASV, p60-Src, SRC1, c-src AND Prognosis
75 results:
1. Inhibition of the RAF/MEK/ERK Signaling Cascade in Pancreatic cancer: Recent Advances and Future Perspectives.
Adamopoulos C; Cave DD; Papavassiliou AG
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338909
[TBL] [Abstract] [Full Text] [Related]
2. The emerging roles of CEACAM6 in human cancer (Review).
Wu G; Wang D; Xiong F; Wang Q; Liu W; Chen J; Chen Y
Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38240103
[TBL] [Abstract] [Full Text] [Related]
3. Compartment-specific multiomic profiling identifies src and GNAS as candidate drivers of epithelial-to-mesenchymal transition in ovarian carcinosarcoma.
Herrington CS; Oswald AJ; Stillie LJ; Croy I; Churchman M; Hollis RL
Br J Cancer; 2024 Feb; 130(2):327-335. PubMed ID: 38097740
[TBL] [Abstract] [Full Text] [Related]
4. src is a target molecule of mannose against pancreatic cancer cells growth in vitro & in vivo.
Xie J; Wu S; Liao W; Ning J; Ding K
Glycobiology; 2023 Oct; 33(10):766-783. PubMed ID: 37658770
[TBL] [Abstract] [Full Text] [Related]
5. Dasatinib and Trametinib Promote Anti-Tumor Metabolic Activity.
Bolf EL; Beadnell TC; Rose MM; D'Alessandro A; Nemkov T; Hansen KC; Schweppe RE
Cells; 2023 May; 12(10):. PubMed ID: 37408209
[TBL] [Abstract] [Full Text] [Related]
6. Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells.
Simbolo M; Silvestris N; Malleo G; Mafficini A; Maggino L; Cocomazzi A; Veghini L; Mombello A; Pezzini F; Sereni E; Martelli FM; Gkountakos A; Ciaparrone C; Piredda ML; Ingravallo G; Paolino G; Nappo F; Rapposelli IG; Frassinetti L; Saragoni L; Lonardi S; Pea A; Paiella S; Fassan M; Brunetti O; Cingarlini S; Salvia R; Milella M; Corbo V; Lawlor RT; Scarpa A; Luchini C
Mod Pathol; 2023 Sep; 36(9):100251. PubMed ID: 37355152
[TBL] [Abstract] [Full Text] [Related]
7. Functional roles of src signaling in pancreatic cancer: Recent insights provide novel therapeutic opportunities.
Poh AR; Ernst M
Oncogene; 2023 Jun; 42(22):1786-1801. PubMed ID: 37120696
[TBL] [Abstract] [Full Text] [Related]
8. Therapeutic Targets and Prognostic Biomarkers Among CXC Chemokines in Pancreatic Ductal Adenocarcinoma Microenvironment.
Yin Z; Chen S
Pancreas; 2022 Oct; 51(9):1235-1247. PubMed ID: 37078951
[TBL] [Abstract] [Full Text] [Related]
9. ALKBH5 activates FAK signaling through m6A demethylation in
Sun R; Yuan L; Jiang Y; Wan Y; Ma X; Yang J; Sun G; Zhou S; Wang H; Qiu J; Zhang L; Cheng W
Theranostics; 2023; 13(2):833-848. PubMed ID: 36632222
[No Abstract] [Full Text] [Related]
10. Targeting src reactivates pyroptosis to reverse chemoresistance in lung and pancreatic cancer models.
Su L; Chen Y; Huang C; Wu S; Wang X; Zhao X; Xu Q; Sun R; Kong X; Jiang X; Qiu X; Huang X; Wang M; Wong PP
Sci Transl Med; 2023 Jan; 15(678):eabl7895. PubMed ID: 36630483
[TBL] [Abstract] [Full Text] [Related]
11. src-3/TRAF4 facilitates ovarian cancer development by activating the PI3K/AKT signaling pathway.
Wang Y; Luo X; Wu N; Liao Q; Wang J
Med Oncol; 2023 Jan; 40(2):76. PubMed ID: 36625999
[TBL] [Abstract] [Full Text] [Related]
12. Selectively Targeting STAT3 Using a Small Molecule Inhibitor is a Potential Therapeutic Strategy for Pancreatic cancer.
Chen H; Zhou W; Bian A; Zhang Q; Miao Y; Yin X; Ye J; Xu S; Ti C; Sun Z; Zheng J; Chen Y; Liu M; Yi Z
Clin Cancer Res; 2023 Feb; 29(4):815-830. PubMed ID: 36374556
[TBL] [Abstract] [Full Text] [Related]
13. SNAP23-Mediated Perturbation of Cholesterol-Enriched Membrane Microdomain Promotes Extracellular Vesicle Production in src-Activated cancer Cells.
Mitani F; Hayasaka R; Hirayama A; Oneyama C
Biol Pharm Bull; 2022; 45(10):1572-1580. PubMed ID: 36184518
[TBL] [Abstract] [Full Text] [Related]
14. Polarity switching of ovarian cancer cell clusters via src family kinase is involved in the peritoneal dissemination.
Kawata M; Kondo J; Onuma K; Ito Y; Yokoi T; Hamanishi J; Mandai M; Kimura T; Inoue M
Cancer Sci; 2022 Oct; 113(10):3437-3448. PubMed ID: 35848881
[TBL] [Abstract] [Full Text] [Related]
15. TNFSF9 promotes metastasis of pancreatic cancer by regulating M2 polarization of macrophages through src/FAK/p-Akt/IL-1β signaling.
Wu J; Wang Y; Yang Y; Liu F; Jiang Z; Jiang Z
Int Immunopharmacol; 2022 Jan; 102():108429. PubMed ID: 34906856
[TBL] [Abstract] [Full Text] [Related]
16. MicroRNA-1252-5p, regulated by Myb, inhibits invasion and epithelial-mesenchymal transition of pancreatic cancer cells by targeting NEDD9.
Xue Y; Wu T; Sheng Y; Zhong Y; Hu B; Bao C
Aging (Albany NY); 2021 Jul; 13(14):18924-18945. PubMed ID: 34314382
[TBL] [Abstract] [Full Text] [Related]
17. NCOA3 is a critical oncogene in thyroid cancer via the modulation of major signaling pathways.
Li Y; Liang J; Dang H; Zhang R; Chen P; Shao Y
Endocrine; 2022 Jan; 75(1):149-158. PubMed ID: 34251576
[TBL] [Abstract] [Full Text] [Related]
18. Targeting eukaryotic elongation factor-2 kinase suppresses the growth and peritoneal metastasis of ovarian cancer.
Erdogan MA; Ashour A; Yuca E; Gorgulu K; Ozpolat B
Cell Signal; 2021 May; 81():109938. PubMed ID: 33539938
[TBL] [Abstract] [Full Text] [Related]
19. Pharmacological effects of vinorelbine in combination with lenvatinib in anaplastic thyroid cancer.
Di Desidero T; Orlandi P; Gentile D; Banchi M; Alì G; Kusmic C; Armanetti P; Cayme GJ; Menichetti L; Fontanini G; Francia G; Bocci G
Pharmacol Res; 2020 Aug; 158():104920. PubMed ID: 32461187
[TBL] [Abstract] [Full Text] [Related]
20. Integrated analysis of gene expression and DNA methylation profiles in ovarian cancer.
Gong G; Lin T; Yuan Y
J Ovarian Res; 2020 Mar; 13(1):30. PubMed ID: 32192517
[TBL] [Abstract] [Full Text] [Related]
[Next]
